1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Chip-based oligonucleotide synthesis is revolutionizing how DNA and RNA are manufactured, driving automation, efficiency, and innovative applications across diagnostics, therapeutics, and genomics.
Market Snapshot: Chip-based Oligonucleotide Synthesis
The chip-based oligonucleotide synthesis market is rapidly advancing, driven by adoption of semiconductor-inspired microfabrication and integrated microfluidic techniques. Segments such as diagnostics, gene therapy, and high-throughput genomics benefit from parallelized, automated nucleic acid assembly. This landscape is shaped by technology convergence, industry collaboration, and global regulatory evolution. During the forecast period, significant commercial and research adoption fuels market growth, with emerging markets and established hubs contributing to expanded scale and new applications.
Scope & Segmentation
This report provides a comprehensive analysis of the chip-based oligonucleotide synthesis market, covering products, applications, technologies, end users, scale, and regions:
- Product Types: DNA oligonucleotides, modified oligonucleotides (locked nucleic acids, morpholino, peptide nucleic acids), RNA oligonucleotides
- Applications: Agriculture biotechnology, diagnostics, genomics and personalized medicine (CRISPR Cas, microarray analysis, next-generation sequencing), research and development, therapeutics
- Technological Approaches: Electrochemical, microfluidic flow-based, photolithography (mask-based, maskless)
- End Users: Academic and research institutes, contract research organizations, diagnostic laboratories, pharmaceutical and biotechnology companies
- Scale: Industrial scale, laboratory scale
- Geographic Regions: Americas (with country and state-level detail), Europe, Middle East & Africa, Asia-Pacific
Key Takeaways
- On-chip DNA and RNA synthesis uses microfabrication to enable parallel, automated nucleic acid assembly, outperforming conventional liquid-phase methods in precision and scale.
- Integrated microfluidic and photolithographic platforms support advanced reaction schemes, enabling site-specific modifications and combinatorial libraries across biotech applications.
- Strategic collaborations between semiconductor and life sciences industries have accelerated innovation, yielding scalable designs and tailored chemistries that support custom oligonucleotide modifications.
- Cost efficiencies, reagent reuse, and reduced waste support broader market accessibility, allowing smaller academic and biotech organizations to adopt high-throughput synthesis capabilities.
- Embedded machine learning for process optimization improves outcomes and reduces turnaround times, driving faster iteration in research, diagnostics, and therapeutic development.
- The evolving regulatory framework is encouraging early integration of quality-by-design, streamlining clinical translation and elevating industry standards.
Tariff Impact on Chip-based Oligonucleotide Synthesis
The 2025 United States tariff policies have affected the import costs of critical inputs such as silicon wafers, photoresists, and specialized reagents. As a result, supply chains are adapting with buffer stocks, longer-term sourcing agreements, and increased interest in domestic manufacturing. These changes are influencing project priorities, promoting reagent-efficient methods, and supporting the emergence of subscription-based service models that offer budget flexibility for end users.
Methodology & Data Sources
This market evaluation employs primary interviews with industry and academic leaders, merged with secondary research from peer-reviewed publications, patents, company data, and regulatory filings. Analytical triangulation and expert review ensure comprehensive, accurate segmentation and trend analysis for chip-based oligonucleotide synthesis.
Why This Report Matters
- Enables senior leaders to identify technology investment priorities and plan supply chain resilience for nucleic acid manufacturing.
- Supports data-driven decisions on collaboration, licensing, and market entry with granular segmentation and regional insights.
- Provides a roadmap for navigating evolving regulatory and economic impacts, including tariff and quality requirements.
Conclusion
Chip-based oligonucleotide synthesis platforms are enabling transformation in molecule manufacturing through convergence of precision engineering and life sciences. Forward-focused strategy benefits from detailed market intelligence, segment analysis, and actionable insights presented in this report.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of microarray-based oligonucleotide synthesis with high-throughput sequencing platforms for improved library quality
5.2. Adoption of enzymatic error correction technologies to enhance fidelity in chip-based oligonucleotide assembly
5.3. Development of on-chip enzymatic synthesis methods reducing production time and reagent consumption in NGS library preparation
5.4. Expansion of customizable high-density oligonucleotide libraries accelerating gene-editing and synthetic biology innovation
5.5. Implementation of real-time optical monitoring and quality control for sequence accuracy in photolithographic DNA chips
5.6. Strategic partnerships between semiconductor fabrication companies and biotech firms to scale chip-based synthesis capacity
5.2. Adoption of enzymatic error correction technologies to enhance fidelity in chip-based oligonucleotide assembly
5.3. Development of on-chip enzymatic synthesis methods reducing production time and reagent consumption in NGS library preparation
5.4. Expansion of customizable high-density oligonucleotide libraries accelerating gene-editing and synthetic biology innovation
5.5. Implementation of real-time optical monitoring and quality control for sequence accuracy in photolithographic DNA chips
5.6. Strategic partnerships between semiconductor fabrication companies and biotech firms to scale chip-based synthesis capacity
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Chip-based Oligonucleotide Synthesis Market, by Product Type
8.1. Introduction
8.2. Dna Oligonucleotides
8.3. Modified Oligonucleotides
8.3.1. Locked Nucleic Acid
8.3.2. Morpholino
8.3.3. Peptide Nucleic Acid
8.4. Rna Oligonucleotides
8.2. Dna Oligonucleotides
8.3. Modified Oligonucleotides
8.3.1. Locked Nucleic Acid
8.3.2. Morpholino
8.3.3. Peptide Nucleic Acid
8.4. Rna Oligonucleotides
9. Chip-based Oligonucleotide Synthesis Market, by Application
9.1. Introduction
9.2. Agriculture Biotechnology
9.3. Diagnostics
9.4. Genomics & Personalized Medicine
9.4.1. Crispr Cas
9.4.2. Microarray Analysis
9.4.3. Next Generation Sequencing
9.5. Research & Development
9.6. Therapeutics
9.2. Agriculture Biotechnology
9.3. Diagnostics
9.4. Genomics & Personalized Medicine
9.4.1. Crispr Cas
9.4.2. Microarray Analysis
9.4.3. Next Generation Sequencing
9.5. Research & Development
9.6. Therapeutics
10. Chip-based Oligonucleotide Synthesis Market, by Technology
10.1. Introduction
10.2. Electrochemical
10.3. Microfluidic Flow Based
10.4. Photolithography
10.4.1. Mask Based Photolithography
10.4.2. Maskless Photolithography
10.2. Electrochemical
10.3. Microfluidic Flow Based
10.4. Photolithography
10.4.1. Mask Based Photolithography
10.4.2. Maskless Photolithography
11. Chip-based Oligonucleotide Synthesis Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Contract Research Organizations
11.4. Diagnostic Laboratories
11.5. Pharmaceutical And Biotechnology Companies
11.2. Academic And Research Institutes
11.3. Contract Research Organizations
11.4. Diagnostic Laboratories
11.5. Pharmaceutical And Biotechnology Companies
12. Chip-based Oligonucleotide Synthesis Market, by Scale
12.1. Introduction
12.2. Industrial Scale
12.3. Laboratory Scale
12.2. Industrial Scale
12.3. Laboratory Scale
13. Americas Chip-based Oligonucleotide Synthesis Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Chip-based Oligonucleotide Synthesis Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Chip-based Oligonucleotide Synthesis Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Agilent Technologies, Inc.
16.3.4. Roche Sequencing Solutions, Inc.
16.3.5. Twist Bioscience Corporation
16.3.6. CustomArray, Inc.
16.3.7. Eurofins Genomics GmbH
16.3.8. GenScript Biotech Corporation
16.3.9. BioAutomation, Inc.
16.3.10. LC Sciences, LLC
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific Inc.
16.3.2. Merck KGaA
16.3.3. Agilent Technologies, Inc.
16.3.4. Roche Sequencing Solutions, Inc.
16.3.5. Twist Bioscience Corporation
16.3.6. CustomArray, Inc.
16.3.7. Eurofins Genomics GmbH
16.3.8. GenScript Biotech Corporation
16.3.9. BioAutomation, Inc.
16.3.10. LC Sciences, LLC
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCHAI
FIGURE 26. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCHSTATISTICS
FIGURE 27. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCHCONTACTS
FIGURE 28. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCHAI
FIGURE 26. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCHSTATISTICS
FIGURE 27. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCHCONTACTS
FIGURE 28. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LOCKED NUCLEIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LOCKED NUCLEIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MORPHOLINO, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MORPHOLINO, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE NUCLEIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE NUCLEIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CRISPR CAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CRISPR CAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MICROFLUIDIC FLOW BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MICROFLUIDIC FLOW BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MASK BASED PHOTOLITHOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MASK BASED PHOTOLITHOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MASKLESS PHOTOLITHOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MASKLESS PHOTOLITHOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY INDUSTRIAL SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY INDUSTRIAL SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 114. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 115. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 118. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 119. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 122. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 123. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 126. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 130. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 131. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 138. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 139. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 209. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 212. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 213. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 216. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 217. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 220. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 221. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 225. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 228. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 229. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 232. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 233. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 236. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 237. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 240. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 257. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 260. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 261. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 264. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 265. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 268. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 269. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 272. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 273. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 276. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 277. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 280. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 281. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 2
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DNA OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LOCKED NUCLEIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LOCKED NUCLEIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MORPHOLINO, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MORPHOLINO, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE NUCLEIC ACID, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PEPTIDE NUCLEIC ACID, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RNA OLIGONUCLEOTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY AGRICULTURE BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CRISPR CAS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CRISPR CAS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY RESEARCH & DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MICROFLUIDIC FLOW BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MICROFLUIDIC FLOW BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MASK BASED PHOTOLITHOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MASK BASED PHOTOLITHOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MASKLESS PHOTOLITHOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MASKLESS PHOTOLITHOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY INDUSTRIAL SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY INDUSTRIAL SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY LABORATORY SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 114. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 115. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 118. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 119. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 120. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 121. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 122. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 123. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 126. CANADA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 130. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 131. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 132. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 133. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 134. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 138. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 139. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 142. MEXICO CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 198. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 200. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 209. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 210. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 211. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 212. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 213. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 214. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 215. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 216. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 217. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 220. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 221. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 224. GERMANY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 225. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 226. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 227. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 228. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 229. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 230. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 231. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 232. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 233. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 234. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 235. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 236. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 237. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 240. FRANCE CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 241. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 244. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 245. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 248. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 257. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 258. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 259. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 260. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 261. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 264. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 265. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 266. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 267. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2018-2024 (USD MILLION)
TABLE 268. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PHOTOLITHOGRAPHY, 2025-2030 (USD MILLION)
TABLE 269. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2018-2024 (USD MILLION)
TABLE 272. ITALY CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY SCALE, 2025-2030 (USD MILLION)
TABLE 273. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2018-2024 (USD MILLION)
TABLE 276. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY MODIFIED OLIGONUCLEOTIDES, 2025-2030 (USD MILLION)
TABLE 277. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2018-2024 (USD MILLION)
TABLE 280. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY GENOMICS & PERSONALIZED MEDICINE, 2025-2030 (USD MILLION)
TABLE 281. SPAIN CHIP-BASED OLIGONUCLEOTIDE SYNTHESIS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 2
Samples
LOADING...
Companies Mentioned
The companies profiled in this Chip-based Oligonucleotide Synthesis market report include:- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies, Inc.
- Roche Sequencing Solutions, Inc.
- Twist Bioscience Corporation
- CustomArray, Inc.
- Eurofins Genomics GmbH
- GenScript Biotech Corporation
- BioAutomation, Inc.
- LC Sciences, LLC
